HANNAH WAGGETT: Open Payments
NPI 1871996173 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 27 payments from 10 companies in 2025. Trend: 2023 $421 · 2024 $685 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $176 |
| Novo Nordisk Inc | 5 | $95 |
| Exact Sciences Corporation | 4 | $71 |
| ABBVIE INC. | 3 | $64 |
| Amgen Inc. | 3 | $58 |
| Lundbeck LLC | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: ZEPBOUND, REXULTI, Cologuard Collection Kit, Ozempic, JARDIANCE, VRAYLAR, TRINTELLIX, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
